[1] Lee, Y. M., & Huh, K. C. (2017). Clinical and Biological Features of Interval Colorectal Cancer. Clinical Endoscopy, 50(3), 254–260. https://doi.org/10.5946/ce.2016.115[2] Samadder, N. J., Curtin, K., Tuohy, T. M. F., Pappas, L., Boucher, K., Provenzale, D., Rowe, K. G., Mineau, G. P., Smith, K., Pimentel, R., Kirchhoff, A. C., & Burt, R. W. (2014). Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology, 146(4), 950–960. https://doi.org/10.1053/j.gastro.2014.01.013[3] Brenner, H., Altenhofen, L., Katalinic, A., Lansdorp-Vogelaar, I., & Hoffmeister, M. (2011). Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. American Journal of Epidemiology, 174(10), 1140–1146. https://doi.org/10.1093/aje/kwr188[4] Chen, T. H., Yen, M. F., Lai, M. S., Koong, S. L., Wang, C. Y., Wong, J. M., Prevost, T. C., & Duffy, S. W. (1999). Evaluation of a selective screening for colorectal carcinoma: the Taiwan Multicenter Cancer Screening (TAMCAS) project. Cancer, 86(7), 1116–1128.